PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Schonfeld Strategic Advisors LLC's Holding History (CIK: 0001665241)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 95,190 Value ($000) $6,323 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 77,068 Value ($000) $4,260 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 287,301 Value ($000) $13,894 Avg Close $41.90 Range $33.70 - $60.60
Q3 2024
Shares 61,026 Value ($000) $2,746 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 49,064 Value ($000) $1,700 Avg Close $29.29 Range $24.22 - $35.96
Q4 2023
Shares 89,113 Value ($000) $2,043 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 154,098 Value ($000) $2,570 Avg Close $19.40 Range $16.33 - $26.81
Q1 2023
Shares 148,992 Value ($000) $3,427 Avg Close $16.79 Range $10.62 - $25.69
Q3 2022
Shares 31,814 Value ($000) $268 Avg Close $9.46 Range $7.68 - $11.97
Q2 2022
Shares 48,032 Value ($000) $380 Avg Close $12.09 Range $6.91 - $25.76
Q1 2022
Shares 13,700 Value ($000) $325 Avg Close $28.17 Range $22.56 - $37.05
Q2 2021
Shares 5,000 Value ($000) $224 Avg Close $33.01 Range $24.14 - $45.93
Q2 2019
Shares 101,800 Value ($000) $1,233 Avg Close $11.06 Range $8.88 - $13.14
Q1 2019
Shares 24,000 Value ($000) $301 Avg Close $8.83 Range $6.38 - $14.36